MoonLake Immunotherapeutics (MLTX) Tax Provisions (2021 - 2026)
MoonLake Immunotherapeutics' (MLTX) quarterly Tax Provisions came in at $622000.0 in Q1 2026, up 306.54% year-on-year from $153000.0 in Q1 2025, and up 150.81% quarter-over-quarter from $248000.0 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Tax Provisions (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Tax Provisions history runs 6 years deep, the most recent figure standing at $622000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions rose 306.54% year-over-year to $622000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 195.89% increase from a year earlier, with the FY2025 full-year figure at $611000.0, up 116.67% from the prior year.
- Tax Provisions advanced to $622000.0 in Q1 2026 per MLTX's latest filing, from $248000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $622000.0 in Q1 2026 and bottomed at $7332.0 in Q1 2022.
- The 5-year median for Tax Provisions is $43920.0 (2023), against an average of $96786.4.
- Biggest YoY gain for Tax Provisions was 678.4% in 2024; the steepest drop was 6.65% in 2024.
- Year by year, Tax Provisions stood at $11012.0 in 2022, then soared by 298.84% to $43920.0 in 2023, then fell by 6.65% to $41000.0 in 2024, then surged by 504.88% to $248000.0 in 2025, then soared by 150.81% to $622000.0 in 2026.
- Per Business Quant, the three latest MLTX Tax Provisions figures stand at $622000.0 (Q1 2026), $248000.0 (Q4 2025), and $115000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.35 Bn | 991.29 Mn | - | 622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 622,000.00 |
| Dec 31, 2025 | 248,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 95,000.00 |
| Mar 31, 2025 | 153,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 43,920.00 |
| Sep 30, 2023 | 28,923.00 |
| Jun 30, 2023 | 10,149.00 |
| Mar 31, 2023 | 11,010.00 |
| Dec 31, 2022 | 11,012.00 |
| Sep 30, 2022 | 8,740.00 |
| Jun 30, 2022 | 9,282.00 |
| Mar 31, 2022 | 7,332.00 |
| Dec 31, 2021 | 4,755.00 |